21 CFR 211
21 CFR Part 211 is the FDA regulation for current good manufacturing practice (cGMP) for finished pharmaceuticals, read together with Part 210.
It covers the organization and personnel, buildings and facilities, equipment, control of components and containers, production and process controls, packaging and labeling, holding and distribution, laboratory controls, records and reports, and returned or salvaged drug products.
Every FDA drug inspection is measured against it, and every Form 483 observation cites a section of it.
In writing, Part 211 requires written procedures for almost everything: production and process control, cleaning and maintenance, component receipt and testing, packaging and labeling operations, laboratory testing and stability, complaint handling, distribution, and returns.
It requires master production and control records and batch production records for every batch, written specifications, and an independent quality control unit with documented authority to approve or reject materials, procedures, and products. The 2026 FDA draft guidance on responding to Form 483 observations shows how seriously the agency treats the written record.
Who has to comply
Any manufacturer, packager, labeler, or holder of finished drug products (human or animal) for the US market, domestic or foreign, including contract manufacturers and testing laboratories. Active pharmaceutical ingredient makers follow the ICH Q7 guidance under the statutory cGMP requirement rather than Part 211 directly.
Compounding pharmacies and outsourcing facilities have their own provisions.
What the assessor asks to see
Quality unit organization and responsibilities; site master file or equivalent overview; written procedures across all subparts; master production and control records and executed batch records; specifications and certificates of analysis; laboratory control records, method validation, stability program, out-of-specification investigations; equipment qualification, calibration, and cleaning validation; process validation reports; change control and deviation records; CAPA system; complaint and field alert records; annual product quality reviews; training records; data integrity controls including audit trails and electronic records under Part 11; distribution and recall records; supplier qualification and audit reports.
Where the requirement sits: 211.22(d) written QC procedures; 211.25 training records; 211.100 written production and process control procedures; 211.180-211.198 records
Every internal policy in one place
AllyMatter is a full system for every internal policy your company keeps, including the ones 21 CFR 211 turns on. Build the whole library in one place, across every department, and prove who has read what.
Start here
ISO 9001 Quality Policy and Documented Information: who needs it, what goes in it, how often it is reviewed and who signs it off. Run exactly that in AllyMatter, alongside every other policy your company keeps.
How it works
Every document is approved by someone other than its author, versioned, distributed to the people it covers and acknowledged by name. Sign it where a signature is what the standard wants, send a set out together as a package, and export a dated record of who read which version when an assessor asks.
The written policies this standard turns on live here, with every version and every acknowledgment on the record.
Who helps with 21 CFR 211
A very mature cGMP consultant ecosystem exists, including former FDA investigators and large quality consultancies. Consultants run mock inspections and gap assessments, write and remediate procedure sets, run data integrity and validation programs, train staff, and manage 483 and warning letter responses and consent decree remediation.
Firms that name this framework in their own material. A listing is not a recommendation. Each firm can confirm its own.
Consultants
Be the first 21 CFR 211 consultant listed here
The people reading this are working out who can help them get there.
Who assesses 21 CFR 211
FDA investigators (government inspection). Foreign regulators under mutual recognition agreements and PIC/S-aligned authorities may inspect the same site for their own markets. (regulatory inspection).
Assessors
Be the first 21 CFR 211 assessor listed here
This page is read by the organizations looking for someone to certify them.
Tools for 21 CFR 211
Tools that name this framework in their own material.
Grouped by type. Inside each group the order is random, reshuffled each time the page loads. AllyMatter, the publisher of this site, is always first.
AllyMatterPolicy management tool, the policy and acknowledgment layerPublisher of this siteRelated reading
- FDA publishes draft guidance on responding to Form 483 observations after a drug CGMP inspectionExplains FDA's 2026 expectations for the content and timing of a 483 response, including the management and quality-system role.Covington & Burling
- FDA issues guidance on responding to FDA Form 483sA second reading of the same draft guidance, with more on section 211.192 investigations and handling technical disagreement with investigators.Arnold & Porter
- Requirements for electronic records contained in 21 CFR 211Untangles which record and signature obligations come from Part 211 itself rather than from Part 11, a common source of confusion.Pharmaceutical Technology
Independent third-party explainers, chosen by hand. Not affiliated with this site and not paid placements. All links are nofollow.
Need a hand implementing it?
Find a Consultant for 21 CFR 211
Tell us what you need done and we will point you to firms that do this work. Your details go to a firm only when you choose it.
From the publisher
Run the Policy Side of 21 CFR 211 in AllyMatter
Approve the policies 21 CFR 211 asks for, keep every version, and record a named acknowledgment from each person who has to read them.